A pharmaceutical composition for pulmonary delivery that is a dry powder that contains a porous carrier particles and active agent particles. The porous carrier particles and the active agent particles form an ordered mixture of respirable agglomerates that are useful to treat diseases of the lung. The active agent particles can comprise one two three or more active ingredients. A spray drying process for preparing the respirable agglomerates is also described.